Prediction of Left Atrial Thrombi in Patients with Atrial Tachyarrhythmias During Warfarin Administration: Retrospective Study in Hyogo College of Medicine

Overview

Journal Heart Vessels

Specialty Cardiology & Vascular Diseases

Date 2014 Mar 25

PMID 24658886

Citations 11

Authors

Hideyuki Kishima

Takanao Mine

Takeshi Kodani

Tohru Masuyama

Affiliations

Soon will be listed here.

Abstract

Some patients experience a left atrial thrombus (LAT) in spite of taking warfarin. We aimed to clarify the characteristics of patients with LAT during warfarin administration and investigated whether the CHADS2 or CHA2DS2-VASc scores are useful predictors of LAT. We studied 230 patients (169 males, age 65 ± 10 years) who underwent transesophageal echocardiography (TEE) prior to cardioversion or catheter ablation of atrial tachyarrhythmias between 2008 and 2012. All patients were taking oral warfarin. LAT was detected in 19 patients (8.3%) using TEE. LAT was significantly associated with the presence of hypertension (P = 0.0035), prior congestive heart failure (P < 0.0001), structural heart disease (P = 0.0012), persistent arrhythmias (P < 0.0001), the absence of SR during TEE (P = 0.0070), left ventricular ejection fraction (P < 0.0001), left atrial diameter (P = 0.0015), left ventricular dimension during end diastole (P = 0.0215), left ventricular hypertrophy (LVH; P < 0.0001), and the E/e' ratio (P = 0.0074). A multivariate analysis showed that LVH (P = 0.0065, OR 5.591, 95% CI 1.618–19.316) and persistent arrhythmia (P = 0.0364, OR 12.121, 95% CI 1.171–125.451) were independently associated with LAT. Moreover, the mean CHADS2 (2.3 ± 0.9 vs. 1.4 ± 1.2) and CHA2DS2-VASc scores (3.8 ± 1.2 vs. 2.8 ± 1.7) were higher in the patients with than without LAT. However, a multivariate analysis showed that the CHADS2/CHA2DS2-VASc scores did not associate with LAT. LVH and persistent arrhythmia may be useful for predicting LAT in patients with atrial tachyarrhythmias.

Citing Articles

Percutaneous left atrial appendage closure in patients with hypertrophic cardiomyopathy and persistent atrial fibrillation: 3-year-followed case series.

Liu Y, Chen C, Chen Y, Su X, Li Z, Chen Y Medicine (Baltimore). 2023; 102(17):e33646.

PMID: 37115077 PMC: 10145963. DOI: 10.1097/MD.0000000000033646.

Electric cardioversion in patients treated with oral anticoagulants: embolic material in the left atrial appendage.

Karwowski J, Rekosz J, Solecki M, Maczynska-Mazuruk R, Wrzosek K, Suminska-Syska J Cardiovasc J Afr. 2022; 34(3):181-188.

PMID: 36478018 PMC: 10658724. DOI: 10.5830/CVJA-2022-060.

Construction of a Clinical Predictive Model of Left Atrial and Left Atrial Appendage Thrombi in Patients with Nonvalvular Atrial Fibrillation.

Yin L, He C, Zheng H, Ma J, Liu J, Zhang X J Interv Cardiol. 2022; 2022:7806027.

PMID: 36419956 PMC: 9652078. DOI: 10.1155/2022/7806027.

Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.

Marroquin L, Tirado-Conte G, Pracon R, Streb W, Gutierrez H, Boccuzzi G Heart. 2021; 108(14):1098-1106.

PMID: 34686564 PMC: 9240333. DOI: 10.1136/heartjnl-2021-319811.

Clinical background including anticoagulant therapy in patients with atrial fibrillation in a community-based survey: the Saitama AF Registry.

Wakabayashi Y, Sugawara Y, Fujita K, Hayashi T, Ikeda N, Umemoto T Heart Vessels. 2017; 32(11):1382-1389.

PMID: 28634694 DOI: 10.1007/s00380-017-1009-0.

References

Schmidt H, von der Recke G, Illien S, Lewalter T, Schimpf R, Wolpert C . Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol. 2001; 38(3):778-84. DOI: 10.1016/s0735-1097(01)01463-2. View

Calkins H, Brugada J, Packer D, Cappato R, Chen S, Crijns H . HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical.... Heart Rhythm. 2007; 4(6):816-61. DOI: 10.1016/j.hrthm.2007.04.005. View

Feng D, Syed I, Martinez M, Oh J, Jaffe A, Grogan M . Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation. 2009; 119(18):2490-7. DOI: 10.1161/CIRCULATIONAHA.108.785014. View

Yamashita E, Takamatsu H, Tada H, Toide H, Okaniwa H, Takemura N . Transesophageal echocardiography for thrombus screening prior to left atrial catheter ablation. Circ J. 2010; 74(6):1081-6. DOI: 10.1253/circj.cj-09-1002. View

Fatkin D, Scalia G, Jacobs N, Burstow D, Leung D, Walsh W . Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus. Am J Cardiol. 1996; 77(4):321-3. DOI: 10.1016/s0002-9149(97)89406-4. View

Yakar Tuluce S, Kayikcioglu M, Tuluce K, Yilmaz M, Ozdogan O, Aydin M . Assessment of left atrial appendage function during sinus rhythm in patients with hypertrophic cardiomyopathy: transesophageal echocardiography and tissue doppler study. J Am Soc Echocardiogr. 2010; 23(11):1207-16. DOI: 10.1016/j.echo.2010.08.016. View

Kimura M, Wasaki Y, Ogawa H, Nakatsuka M, WAKEYAMA T, Iwami T . Effect of low-intensity warfarin therapy on left atrial thrombus resolution in patients with nonvalvular atrial fibrillation: a transesophageal echocardiographic study. Jpn Circ J. 2001; 65(4):271-4. DOI: 10.1253/jcj.65.271. View

. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology. 2007; 69(6):546-54. DOI: 10.1212/01.wnl.0000267275.68538.8d. View

Lang R, Bierig M, Devereux R, Flachskampf F, Foster E, Pellikka P . Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of.... J Am Soc Echocardiogr. 2005; 18(12):1440-63. DOI: 10.1016/j.echo.2005.10.005. View

10.

Santiago D, Warshofsky M, Li Mandri G, Di Tullio M, Coromilas J, Reiffel J . Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol. 1994; 24(1):159-64. DOI: 10.1016/0735-1097(94)90557-6. View

11.

Corrado G, Sgalambro A, Mantero A, Gentile F, Gasparini M, Bufalino R . Thromboembolic risk in atrial flutter. The FLASIEC (FLutter Atriale Società Italiana di Ecografia Cardiovascolare) multicentre study. Eur Heart J. 2001; 22(12):1042-51. DOI: 10.1053/euhj.2000.2427. View

12.

Fatkin D, Kelly R, Feneley M . Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 1994; 23(4):961-9. DOI: 10.1016/0735-1097(94)90644-0. View

13.

Goldman M, Pearce L, Hart R, Zabalgoitia M, Asinger R, Safford R . Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr. 1999; 12(12):1080-7. DOI: 10.1016/s0894-7317(99)70105-7. View

14.

Cappato R, Calkins H, Chen S, Davies W, Iesaka Y, Kalman J . Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005; 111(9):1100-5. DOI: 10.1161/01.CIR.0000157153.30978.67. View

15.

Khasnis A, Jongnarangsin K, Abela G, Veerareddy S, Reddy V, Thakur R . Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol. 2005; 28(7):710-21. DOI: 10.1111/j.1540-8159.2005.00143.x. View

16.

Fujiwara M, Watanabe H, Oguma Y, Yamaura G, Ishibashi K, Yamamoto H . A free-floating left atrial thrombus develops intermittent entrapment in the mid-ventricle during diastole. Heart Vessels. 2011; 27(4):428-31. DOI: 10.1007/s00380-011-0199-0. View

17.

Scherr D, Dalal D, Chilukuri K, Dong J, Spragg D, Henrikson C . Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008; 20(4):379-84. DOI: 10.1111/j.1540-8167.2008.01336.x. View

18.

Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K . Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. Jpn Circ J. 1995; 59(6):329-36. DOI: 10.1253/jcj.59.329. View

19.

Lip G, Nieuwlaat R, Pisters R, Lane D, Crijns H . Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2009; 137(2):263-72. DOI: 10.1378/chest.09-1584. View

20.

. Determinants of warfarin use and international normalized ratio levels in atrial fibrillation patients in Japan. - Subanalysis of the J-RHYTHM Registry-. Circ J. 2011; 75(10):2357-62. DOI: 10.1253/circj.cj-11-0427. View